Trial Profile

Phase 3 study of AMT-101 in chronic pouchitis

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 07 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AMT 101 (Primary)
Indications Pouchitis
Focus Therapeutic Use

Most Recent Events

27 Dec 2023 According to Cyclo Therapeutics media release, Applied Molecular Transport has merged with Cyclo Therapeutics to form Cyclo Therapeutics
18 May 2022 According to an Applied Molecular Transport media release, the company is Preparing for end of Phase 2 meetings with FDA and other regulators to advance AMT-101 to Phase 3 in chronic pouchitis
26 Apr 2022 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com